Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin

Ovarian cancer (OC) is a refractory cancer that shows recurrence due to the acquisition of resistance to anticancer drugs, including cisplatin. However, the molecular mechanism underlying the acquisition of cisplatin resistance by cancer cells remains largely unknown. In the present study, two sets...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Ryosuke, Kamizaki, Koki, Yamanaka, Keitaro, Terai, Yoshito, Minami, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196713/
https://www.ncbi.nlm.nih.gov/pubmed/37144519
http://dx.doi.org/10.3892/or.2023.8561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196713/
https://www.ncbi.nlm.nih.gov/pubmed/37144519
http://dx.doi.org/10.3892/or.2023.8561

Ejemplares similares